Quarterly report [Sections 13 or 15(d)]

Business Combinations - Additional Information (Details)

v3.26.3
Business Combinations - Additional Information (Details) - USD ($)
 3 Months Ended 4 Months Ended
Aug. 31, 2026
May 05, 2026
Aug. 31, 2026
Aug. 31, 2025
Aug. 31, 2026
Business Combination [Line Items]          
Stock price (in dollars per share)   $ 13.22      
Fair value adjustment of goodwill acquired in reverse merger acquisition     $ 126,000 $ 0  
Private Placement          
Business Combination [Line Items]          
Number of shares sold in transaction (in shares)   1,311,407      
Public offering price per share (in dollars per share)   $ 12.01      
Proceeds from equity funding   $ 15,800,000      
Placement Agent fee paid, percent   5.00%      
Placement Agent fee paid   $ 800,000      
Consideration received on sale of stock   $ 15,000,000.0      
Ekso Bionics Holdings, Inc. | Applied Parent and APLD Intermediate HoldCo LLC          
Business Combination [Line Items]          
Parent, ownership percentage   97.00%      
Ekso Bionics Holdings, Inc. | Legacy Ekso Shareholders          
Business Combination [Line Items]          
Noncontrolling owner, ownership percentage   3.00%      
Ekso Bionics Holdings, Inc.          
Business Combination [Line Items]          
Shares assumed (in shares)   1,200      
Ownership percentage   100.00%      
Holding Company Transaction          
Business Combination [Line Items]          
Shares issued (in shares)   138,216,820 4,277,076    
Purchase consideration to be allocated $ 57,623,000 $ 57,623,000 $ 57,623,000    
Value of restricted stock awards assumed $ 1,080,000   1,080,000   $ 1,080,000
Goodwill, tax deductible amount   $ 0      
Fair value adjustment of goodwill acquired in reverse merger acquisition     100,000   126,000
Current liabilities held for sale, Adjustments     $ 100,000   $ 126,000